Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness Pharmaceutical Investing
BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference Pharmaceutical Investing
Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases Life Science Investing
PEPFAR and The Global Fund Make Additional Investment in Gilead's Lenacapavir for HIV Prevention to Further Expand Access Life Science Investing
Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613 Life Science Investing
Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026 Life Science Investing
AbbVie Showcases Late?Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx in Platinum?Sensitive Ovarian Cancer at SGO 2026 Pharmaceutical Investing
Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders Pharmaceutical Investing
